Polymerase News and Research

RSS

What are the risk factors for severe disease in children hospitalized for SARS-CoV-2 infection?

A new preprint describes an effort to describe the risk factors for severe COVID-19 in children.

2 Nov 2021

Rice introduces new online portal to help researchers screen COVID-19 drug candidates

Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus.

1 Nov 2021

Curious case of SARS-CoV-2 Delta variant in a dog

In a recent study, researchers document the detection and sequencing of an AY.3 virus from a 12-year-old Collie living with a SARS-CoV-2-infected owner.

1 Nov 2021

New genetic epidemiology tool provides detailed information about viruses, coinfections

With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID.

1 Nov 2021

Do weather and climate determine where COVID-19 occurs?

A new study provides information on the associations between weather parameters and seasonal coronavirus cases.

1 Nov 2021

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

A cohort study found that antibodies to the SARS-CoV-2 spike protein and neutralizing antibodies remain relatively stable 8-11 months post-infection.

1 Nov 2021

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

1 Nov 2021

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

The researchers investigated the neutralizing activity of turmeric root extract, curcumin-containing capsules, and pure curcumin against SARS-CoV-2.

1 Nov 2021

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.

1 Nov 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

In a study published in Annals of Internal Medicine, researchers from Italy systematically monitored 2,397 HCWs who were fully vaccinated with BNT162 at the ASST Settelaghi hospitals in Lombardy, Italy during February 2021. HCWs who worked in 8 wards deemed at “high risk” for infection from attending patients had to undergo mandatory nasopharyngeal swab testing with SARS-CoV-2 polymerase chain reaction every two weeks. HCWs working in 8 “moderate-risk” wards were tested every four weeks.

28 Oct 2021

Polymerase News and Research

What are the risk factors for severe disease in children hospitalized for SARS-CoV-2 infection?

Rice introduces new online portal to help researchers screen COVID-19 drug candidates

Curious case of SARS-CoV-2 Delta variant in a dog

New genetic epidemiology tool provides detailed information about viruses, coinfections

Do weather and climate determine where COVID-19 occurs?

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

The ability of natural flavonoids to inhibit SARS-CoV-2

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News